Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

Neuro-oncology advances·2026
Same author

A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations.

Cancer research·2026
Same author

Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression.

Nature communications·2025
Same author

Evidences of neurological injury caused by COVID-19 from glioma tissues and glioma organoids.

CNS neuroscience & therapeutics·2024
Same author

Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape.

Signal transduction and targeted therapy·2023
Same author

Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma.

Journal of the National Cancer Institute·2023

Related Experiment Video

Updated: Dec 21, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.6K

Classification of diffuse lower-grade glioma based on immunological profiling.

Fan Wu1,2,3, Zhi-Liang Wang1,2,3, Kuan-Yu Wang1,2,3

  • 1Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

Molecular Oncology
|May 12, 2020
PubMed
Summary

This study identified three distinct immune subtypes in diffuse lower-grade glioma (LGG) using transcriptomic data. These subtypes, characterized by immune cell infiltration and genetic alterations, offer potential for personalized immunotherapy strategies.

Keywords:
diffuse lower-grade gliomaimmune classificationprognosistumor microenvironment

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.3K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.0K

Related Experiment Videos

Last Updated: Dec 21, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.6K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.3K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.0K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Transcriptomic data aids in understanding the tumor microenvironment (TME) and immune subtypes for cancer immunotherapy.
  • Diffuse lower-grade glioma (LGG) requires better stratification for effective treatment strategies.

Purpose of the Study:

  • To identify and characterize distinct immune subtypes within diffuse lower-grade glioma (LGG) using transcriptomic data.
  • To evaluate the clinical relevance and prognostic value of identified immune subtypes in LGG.
  • To develop a predictive immune signature for LGG prognosis.

Main Methods:

  • Consensus clustering of gene expression data from 402 LGG patients (TCGA cohort).
  • Validation in three Chinese Glioma Genome Atlas (CGGA) cohorts.
  • Integration of immunogenomic methods and graph structure learning for immune landscape analysis.

Main Results:

  • Identification and validation of three immune subtypes (Im1, Im2, Im3) in LGG.
  • Subtypes differ in immune cell infiltration (e.g., CD8+ T cells, macrophages), somatic alterations, and clinical outcomes.
  • Im2 subtype associated with higher cytolytic activity, exhausted CD8+ T cells, aneuploidy, tumor mutation burden, and worst prognosis.
  • Distinct intracluster heterogeneity observed within the Im2 subtype.
  • A validated immune signature demonstrated improved prognostic prediction.

Conclusions:

  • Diffuse LGG exhibits significant immunological heterogeneity.
  • The identified immune subtypes provide a basis for stratifying patients for immunotherapy.
  • The developed immune signature enhances prognostic prediction in LGG.